You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 62011-0436


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 62011-0436

Drug Name NDC Price/Unit ($) Unit Date
HM STOMACH RELIEF 525 MG/15 ML 62011-0436-01 0.01022 ML 2025-01-22
HM STOMACH RELIEF 525 MG/15 ML 62011-0436-01 0.01030 ML 2024-12-18
HM STOMACH RELIEF 525 MG/15 ML 62011-0436-01 0.01054 ML 2024-11-20
HM STOMACH RELIEF 525 MG/15 ML 62011-0436-01 0.01054 ML 2024-10-23
HM STOMACH RELIEF 525 MG/15 ML 62011-0436-01 0.00990 ML 2024-09-18
HM STOMACH RELIEF 525 MG/15 ML 62011-0436-01 0.01035 ML 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 62011-0436

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 62011-0436

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. It includes the labeler code, product code, and package code[1].

Identifying the Drug

The NDC 62011-0436 is associated with a specific drug product. To identify the drug, one would typically refer to the FDA's NDC Directory or other databases that list drug names and their corresponding NDCs. However, without direct access to these databases in this context, we can infer general trends and factors that influence drug prices.

Market Trends in the Pharmaceutical Industry

Global and U.S. Market Comparison

The pharmaceutical market, particularly in the U.S., is characterized by significantly higher drug prices compared to other regions. According to ASPE, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as the rest of the world (excluding the U.S.) in 2022[3].

Sales Revenue Trends

U.S. sales revenues for pharmaceuticals have shown substantial growth. For instance, between 2017 and 2022, U.S. sales revenues grew by 22% in retail markets and 26% in non-retail markets, such as hospitals and physician offices. In contrast, the rest of the world and OECD countries saw declines in retail markets but growth in non-retail markets[3].

Drug Price Inflation

Drug prices in the U.S. have been increasing. Between 2017 and 2022, there was an average price increase of 14% for all drugs. This trend is expected to continue, with a projected 3.81% drug price inflation rate[2][3].

Factors Influencing Drug Prices

Regulatory Environment

The regulatory environment plays a significant role in drug pricing. For example, outsourcing facilities that compound drugs under Section 503B of the FD&C Act may be exempt from certain approval requirements but must still report their products to the FDA, which can impact pricing transparency and competition[1].

Market Dynamics

The mix of small molecule drugs and biologic products also influences market trends. Biologic products have seen significant growth, with U.S. sales revenues increasing by 61% between 2017 and 2022, while small molecule drugs saw more modest growth of 4% during the same period[3].

Price Projections for NDC 62011-0436

Given the general trends in the pharmaceutical industry:

Expected Price Increases

  • The drug associated with NDC 62011-0436 is likely to experience price increases in line with the overall market trend. With a projected 3.81% drug price inflation rate, one can expect the price of this drug to rise accordingly[2].

Comparative Pricing

  • If the drug is a small molecule or biologic product, its price trend will follow the respective category's growth. Biologic products, in particular, have seen substantial price increases, so if the drug falls into this category, it may experience more significant price hikes[3].

Regulatory and Reporting Requirements

  • The drug's pricing could also be influenced by regulatory requirements and reporting obligations. For instance, if the drug is produced by an outsourcing facility, the facility's reporting and compliance with FDA regulations could impact pricing transparency and competition[1].

Example of Price Trends

To illustrate, consider the price trends for another drug, MULPLETA 3MG TAB (NDC 59630-0551). The price per unit for this drug has seen significant variations, with prices ranging from $908.69 to $1,195.98 per unit, depending on the vendor and pricing type. This variability highlights the complex nature of drug pricing and the need for continuous monitoring of market trends[2].

Key Takeaways

  • Market Trends: The U.S. pharmaceutical market is characterized by high and increasing drug prices.
  • Regulatory Impact: FDA regulations and reporting requirements can influence drug pricing and transparency.
  • Category-Specific Growth: Biologic products have seen more significant price increases compared to small molecule drugs.
  • Price Inflation: A projected 3.81% drug price inflation rate suggests that prices for most drugs, including NDC 62011-0436, are likely to rise.

FAQs

What is the National Drug Code (NDC)?

The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs, including the labeler code, product code, and package code[1].

How do regulatory requirements affect drug pricing?

Regulatory requirements, such as those for outsourcing facilities, can impact pricing transparency and competition by influencing the reporting and compliance obligations of drug manufacturers[1].

Why are drug prices in the U.S. higher than in other countries?

Drug prices in the U.S. are higher due to a combination of factors, including a drug mix that skews towards more expensive compounds and higher prices for the same drugs compared to other regions[3].

What is the projected drug price inflation rate?

The projected drug price inflation rate is 3.81%, indicating that drug prices are expected to continue rising[2].

How do biologic products differ from small molecule drugs in terms of price trends?

Biologic products have seen more significant price increases, with a 61% growth in U.S. sales revenues between 2017 and 2022, compared to a 4% growth for small molecule drugs during the same period[3].

Sources

  1. FDA: National Drug Code Directory - FDA
  2. DrugPatentWatch: Latest drug prices and trends for NDC 59630-0551
  3. ASPE: ISSUE BRIEF - International Market Size and Prices
  4. CMS: Drug Name and National Drug Code (NDC) Reference Data Instructions
  5. Maryland Department of Health: National Drug Code (NDC) Conversion Table

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.